Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H2B.N (abbreviated H2B.N; gene: H2BN1) is a variant of the canonical histone H2B, functioning as a core component of nucleosomes in chromatin. Unlike replication-coupled canonical histones, H2B.N is predominantly expressed in mammalian oocytes and early zygotes and is thought to contribute to unusual chromatin packaging or potentially nonchromatin functions in the mammalian germline. It is part of a small group of mammalian-specific H2B variants, recently identified through phylogenomic studies. There are no known disease roles, clinical biomarkers, or targeted therapeutics associated with H2B.N at this time
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H2B.N (H2B.N).